Pacira BioSciences, Inc. PCRX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s total liabilities?
- Pacira BioSciences, Inc. (PCRX) reported total liabilities of $554.64M in Q1 2026.
- How has Pacira BioSciences, Inc.'s total liabilities changed year-over-year?
- Pacira BioSciences, Inc.'s total liabilities decreased by 29.6% year-over-year, from $788.13M to $554.64M.
- What is the long-term trend for Pacira BioSciences, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s total liabilities has grown at a -2.7% compound annual growth rate (CAGR), from $654.83M to $571.81M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.